<DOC>
	<DOCNO>NCT01250652</DOCNO>
	<brief_summary>Allen Kaplan prominent American allergist reputation leader field chronic urticaria . He advocate treatment first generation hydroxyzine , considers least effective modern second generation H1-blockers suppressing symptom difficult-to-treat / systemic-steroid-dependant case chronic urticaria . He speculate hydroxyzine may advantage good suppress itch improve nighttime sleep . This prompt many practitioner around world believe add hydroxyzine treatment regimen bed time night may beneficial patient . At time European guideline indicate modern second generation H1-blockers high conventional dos drug choice case . However , evidence clinical trial address controversy . The investigator ' previous study suggest levocetirizine quadruple dos may beneficial difficult treat urticaria reduce lesion itch , improve quality life night time sleep , cause day time somnolence . First generation H1-receptor antagonist hydroxyzine among known penetrate blood / brain barrier cause sedation . The question stay whether sedation beneficial subject chronic urticaria night , whether hang-over unwanted effect follow day whether influence overall urticaria-specific quality life .</brief_summary>
	<brief_title>Levocetirizine Plus Bed-Time Hydroxyzine Management Corticodependent Chronic Urticaria Versus Levocetirizine Alone High Doses</brief_title>
	<detailed_description>Study design : The study involve two distinct part ( flow chart ) : 1 . In-hospital assessment effectiveness tolerability 10 &amp; 20 mg levocetirizine vs. 100 &amp; 200 mg hydroxyzine subject wean corticosteroid treatment . 2 . Subsequent ambulatory treatment patient 20 mg levocetirizine alone 15 mg levocetirizine + 50 hydroxyzine night Protocol description Patients chronic urticaria treat systemic steroid traditionally admit Clinic Allergy Asthma Sofia try wean class drug . Hospitalized patient invited take part study sign inform consent . They assess standard questionnaire objective assessment urticarial lesion , QoLQ fill , discomfort due urticaria , day time somnolence night time sleep quality assess visual analogue scale . Systemic steroid withhold patient would give 10 mg levocetirizine Days 1 &amp; 2 ; new assessment quality night time sleep day time somnolence , 100 mg hydroxyzine give Days 3 &amp; 4 . The cycle repeat Days 5 &amp; 6 Days 7 &amp; 8 20 mg levocetirizine 200 hydroxyzine respectively . At point patient discharge randomized two treatment arm : levocetirizine 20 mg per day levocetirizine 15 mg + hydroxyzine 50 mg even dose 5 day . Diaries give patient assessment daily SS , day time somnolence score , quality night time sleep , facial tissue swell , rescue medication oral prednisolone , adverse event , intake medication . After 5 day patient arm 1 2 crossed alternative treatment . QoLQ questionnaire fill onset , cross ( day 5 ) end 10 day treatment period . On completion study subject ask state preference one treatment .</detailed_description>
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<mesh_term>Hydroxyzine</mesh_term>
	<criteria>24 randomized patient either sex , â‰¥18 year age . Included patient least 6week documented history urticaria intake 1530 mg Prednisolon . Patients physically induced urticaria ; pregnancy lactation ; chronic disease require daily drug treatment include , antihypertensive , antipsychotic antidepressant ; skin disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Chronic urticaria</keyword>
	<keyword>Urticaria</keyword>
	<keyword>Antihistamine</keyword>
</DOC>